Clinical Sequencing Exploratory Research (CSER)
United States of America (USA)
1 May 2020 - 1 April 2021
Research collaboration: Clinical Sequencing Exploratory Research (CSER) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Clinical Sequencing Exploratory Research (CSER)
Partner Institutions
Clinical Sequencing Exploratory Research (CSER) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Boston Children's Hospital (BCH), United States of America (USA)
- Brigham and Women's Hospital (BWH), United States of America (USA)
- Dana-Farber Cancer Institute (DFCI), United States of America (USA)
- Columbia University in the City of New York (CU), United States of America (USA)
- Children's Hospital of Philadelphia (CHOP), United States of America (USA)
- Johns Hopkins University (JHU), United States of America (USA)
- NIH National Human Genome Research Institute (NHGRI), United States of America (USA)
- NIH National Cancer Institute (NCI), United States of America (USA)
- The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
- Vanderbilt University (VU), United States of America (USA)
- University of Michigan (U-M), United States of America (USA)
- HudsonAlpha Institute for Biotechnology, United States of America (USA)
- University of Minnesota (UMN), United States of America (USA)
- Mayo Clinic, United States of America (USA)
- Children’s Mercy Kansas City, United States of America (USA)
- Baylor College of Medicine (BCM), United States of America (USA)
- University of Washington (UW), United States of America (USA)
- Seattle Children's Hospital, United States of America (USA)
- Kaiser Permanente, United States of America (USA)
- University of California, San Francisco (UCSF), United States of America (USA)
